Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Firms Up Plans For Unitary Supplementary Protection Certificates

An Impact Assessment Is On The Way

Executive Summary

A unified system for granting SPCs would significantly reduce the burden of seeking protection in up to 27 different EU countries, and would sit well alongside Europe's future unitary patent system, says the European Commission. It is now preparing an impact assessment for the proposal.

You may also be interested in...



EU Sets New Date For Publication Of Delayed Pharma Revision Proposals

Lengthy legislative procedures are expected after the commission publishes its “pharma package” and the “patent package,” which are now due towards the end of April.

EU Sets New Date For Publication Of Delayed Pharma Revision Proposals

Lengthy legislative procedures are expected after the commission publishes its “pharma package” and the “patent package,” which are now due towards the end of April.

Industry Skeptical Of EU Moves To Facilitate Compulsory Licensing

Industry representatives in the EU are more welcoming of moves to harmonize supplementary protection certificates, which they say will bring more certainty for stakeholders.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS145839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel